Furthermore, high tumor-CTGF correlated with remarkable earlier recurrence (p < 0.001) (Figure 1B), while the patient recurrence time between high stroma-CTGF group and low stroma-CTGF group was no difference either (p = 0.12) (Figure 1D). Here, CCN2 is linked to neoplasm.